BioCentury
ARTICLE | Company News

NasVax, Protea Vaccine Technologies deal

December 15, 2008 8:00 AM UTC

NasVax plans to acquire fellow vaccine company Protea for cash and stock. NasVax's offer includes $125,000 in cash up front and a second $125,000 payment when Protea closes a separate deal with an und...